Anzeige
Mehr »
Login
Freitag, 17.09.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Große Spekulation: Der Festtagsbraten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PWSL ISIN: US74365A3095 Ticker-Symbol: PBDA 
Tradegate
15.09.21
13:14 Uhr
1,150 Euro
+0,020
+1,77 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PROTALIX BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PROTALIX BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0901,14016.09.

Aktuelle News zur PROTALIX BIOTHERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PROTALIX BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
26.08.Protalix BioTherapeutics, Inc. - 8-K, Current Report6
16.08.Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2021 Results - Earnings Call Transcript6
16.08.Protalix BioTherapeutics Inc. Q2 Earnings Summary195JERUSALEM (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):-Earnings: -$11.24 million in Q2 vs. -$4.150 million in the same period last year. -EPS: -$0.25...
► Artikel lesen
16.08.Protalix BioTherapeutics EPS misses by $0.17, beats on revenue3
15.08.Protalix BioTherapeutics Q2 2021 Earnings Preview2
13.08.Protalix BioTherapeutics, Inc. - 8-K, Current Report3
02.08.Protalix Bio submits Type A meeting request to FDA for PRX-102 in Fabry disease8
23.06.Protalix Beaten Down By Covid Logistics, But Continues To Show Good Data13
02.06.Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide14
02.06.Protalix, Chiesi Global Announce Topline Results From The Interim Analysis Of Balance Study358WASHINGTON (dpa-AFX) - Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., reported positive initial top line results from the Phase...
► Artikel lesen
02.06.Protalix BioTherapeutics, Inc. - 8-K, Current Report11
20.05.Protalix to propose virtual inspection to clear barrier to FDA approval13
14.05.Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2021 Results - Earnings Call Transcript5
14.05.EARNINGS SUMMARY: Details Of Protalix BioTherapeutics Inc. Q1 Earnings Report548WASHINGTON (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):-Earnings: -$5.47 million in Q1 vs. $1.66 million in the same period last year. -EPS: -$0.14...
► Artikel lesen
14.05.EARNINGS SUMMARY: Details of Protalix BioTherapeutics Inc. Q1 Earnings Report518JERUSALEM (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):-Earnings: -$5.47 million in Q1 vs. $1.66 million in the same period last year. -EPS: -$0.14...
► Artikel lesen
14.05.Protalix swings to Q1 net loss, but beats on EPS and revenue estimates2
14.05.EARNINGS SUMMARY: Details of Protalix BioTherapeutics Inc. Q1 Earnings Report215JERUSALEM (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):-Earnings: -$5.48 million in Q1 vs. $1.66 million in the same period last year. -EPS: -$0.14...
► Artikel lesen
14.05.Protalix BioTherapeutics, Inc. - 10-Q, Quaterly Report3
14.05.Protalix BioTherapeutics, Inc. - 8-K, Current Report4
14.05.Protalix BioTherapeutics EPS beats by $0.03, beats on revenue5
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1